Japanese Pharma Assessing Damage To Plants Amidst Country’s Largest National Disaster; Production Delays Expected
Executive Summary
TOKYO – Following a massive earthquake, tsunami, and potential nuclear disaster, Japan’s leading pharmaceutical companies such as Astellas Pharma Inc. are joining the rest of the country in assessing the damage and taking stock of what needs to be done versus what can be done.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.